Odenthal, Germany

Klaus Grohe


Average Co-Inventor Count = 3.1

ph-index = 17

Forward Citations = 1,163(Granted Patents)


Inventors with similar research interests:


Location History:

  • Cologne, DE (1976 - 1977)
  • Leverkusen, DE (1986)
  • Bayerwerk, DE (1991)
  • Odenthal, DE (1980 - 1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
Areas of Expertise:
Quinolonecarboxylic Acids
Naphthyridonecarboxylic Acid Derivatives
Antibacterial Agents
Halogenated Compounds
Amino Acid Derivatives
Bactericidal Formulations
Veterinary Medicine
Chemical Intermediates
Pharmaceutical Preparations
Quinoline Derivatives
Aza-Bicyclic Compounds
Trifluorobenzoyl Chloride
98 patents (USPTO):Explore Patents

Title: Klaus Grohe: A Pioneer in Antibacterial Innovation

Introduction:

In the world of pharmaceutical research, Klaus Grohe has emerged as a prominent figure. With an impressive track record of 96 patents to his name, Grohe has made significant contributions to the field of antibacterial agents. Working at Bayer Aktiengesellschaft, Grohe has been instrumental in developing novel compounds aimed at combating bacterial infections. This article explores Grohe's latest patents, career highlights, collaborations, and highlights his pivotal role in advancing antibacterial research.

Latest Patents:

Grohe's recent patents showcase his dedication to developing effective antibacterial solutions. One of his noteworthy inventions relates to intermediates for 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinoline-carboxylic acids. These compounds exhibit potent antibacterial properties and hold great promise in combating resistant bacteria. Additionally, Grohe has patented 1,6-naphthyridonecarboxylic acid derivatives. These novel derivatives serve as the foundation for antibacterial compositions, feed additives, and other applications, showcasing Grohe's versatility in addressing antibacterial challenges.

Career Highlights:

Throughout his career, Klaus Grohe has demonstrated his expertise in pharmaceutical research. With 96 patents under his belt, he has consistently pushed the boundaries of antibacterial innovation. Grohe's relentless pursuit of breakthroughs has garnered him recognition as a leading innovator in the field. His research and development efforts have contributed to the creation of novel compounds that have the potential to revolutionize antibacterial treatments.

Collaborations:

Collaboration is key in driving innovation. Klaus Grohe has had the privilege of working with esteemed colleagues, further enriching his research endeavors. Notable among these collaborations are his partnerships with Hans-Joachim Zeiler and Karl G. Metzger. These collaborations have brought together the expertise of multiple researchers, facilitating the development of more innovative and effective antibacterial solutions. Together, they have explored new avenues, shared knowledge, and collectively advanced the field of research.

Conclusion:

Klaus Grohe's vast experience and multitude of patents solidify his role as a pioneer in antibacterial innovation. Through his research and collaborations, he has proven himself to be an invaluable asset in the fight against bacterial infections. His latest patents highlight his ability to develop compounds with potent antibacterial properties, contributing to the development of novel antibiotic treatments. Grohe's unwavering commitment to research and his remarkable career achievements position him as a leading figure in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…